Table of Contents

company-logo

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; osteoporosis, including Actemra, Edirol, and Bonviva; renal diseases consist of Mircera and Oxarol; and neurology/other diseases comprise Hemlibra, CellCept, and Enspryng. It has various development product candidates in the areas of oncology, bone and joint diseases, autoimmune diseases, renal diseases, neurology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances with Roche Group; and collaboration and joint research with academia. The company was founded in 1925 and is headquartered in Tokyo, Japan. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd.

Chugai Pharmaceutical Dividend Announcement

• Chugai Pharmaceutical announced a semi annually dividend of $0.12 per ordinary share which will be made payable on 2024-04-01. Ex dividend date: 2023-12-28
• Chugai Pharmaceutical annual dividend for 2023 was $0.22
• Chugai Pharmaceutical's trailing twelve-month (TTM) dividend yield is 0.53%
• Chugai Pharmaceutical's payout ratio for the trailing twelve months (TTM) is 36.97%

Chugai Pharmaceutical Dividend History

Ex-Div dateDividend amountDividend typePay date
2023-12-28$0.12semi annually2024-04-01
2023-06-29$0.10semi annually2023-09-14
2022-12-29$0.11semi annually2023-04-14
2022-06-28$0.11semi annually2022-09-14

Chugai Pharmaceutical Dividend per year

Chugai Pharmaceutical Dividend Yield

Chugai Pharmaceutical current trailing twelve-month (TTM) dividend yield is 0.53%. Interested in purchasing Chugai Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:

Chugai Pharmaceutical Financial Ratios

P/E ratio16.23
PEG ratio-0.02
P/B ratio3.29
ROE21.67%
Payout ratio36.97%
Current ratio5.09
Quick ratio4.17
Cash Ratio1.36

Chugai Pharmaceutical Dividend FAQ

Does Chugai Pharmaceutical stock pay dividends?
Chugai Pharmaceutical does not currently pay dividends to its shareholders.
Has Chugai Pharmaceutical ever paid a dividend?
No, Chugai Pharmaceutical has no a history of paying dividends to its shareholders. Chugai Pharmaceutical is not known for its dividend payments.
Why doesn't Chugai Pharmaceutical pay dividends?
There are several potential reasons why Chugai Pharmaceutical would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Chugai Pharmaceutical ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Chugai Pharmaceutical has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Chugai Pharmaceutical a dividend aristocrat?
Chugai Pharmaceutical is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Chugai Pharmaceutical a dividend king?
Chugai Pharmaceutical is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Chugai Pharmaceutical a dividend stock?
No, Chugai Pharmaceutical is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Chugai Pharmaceutical stocks?
To buy Chugai Pharmaceutical you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Chugai Pharmaceutical stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.